Tris Pharma Inc
16 drugs in NADAC|16 Generic,0 Brand
View Recalls (8)Tris Pharma Inc lists 16 NDCs in the CMS NADAC file (16 generic, 0 brand), at an average NADAC of $0.36 per unit, with a week-over-week move of +1.6% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
16
16G / 0B
Avg Price / Unit
$0.3577
$0.05 – $1.06
Avg 7d Change
+1.61%
Across 6 drugs with changes
7d Activity
of 16 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Pregabalin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Atypical Antipsychotic therapeutic class
Review the broader class where Tris Pharma Inc has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Tris Pharma Inc make?
Tris Pharma Inc lists 16 NDCs in the CMS NADAC file — 16 generic and 0 brand products.
What is the average price of Tris Pharma Inc drugs?
The average NADAC across Tris Pharma Inc's portfolio is $0.3577 per unit, ranging from $0.0535 to $1.0557.
What types of drugs does Tris Pharma Inc make?
Tris Pharma Inc makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Atypical Antipsychotic (4), Xanthine Oxidase Inhibitor (2).
Has Tris Pharma Inc had any drug recalls?
8 FDA recalls are matched to Tris Pharma Inc in the openFDA feed, most recently on Jul 11, 2019.
How has Tris Pharma Inc's pricing changed recently?
Over the past 7 days, 4 Tris Pharma Inc products rose and 2 fell, with a portfolio-wide average change of +1.6%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PALIPERIDONE ER 9 MG TABLET paliperidone | $1.0557 per EA | +3.64% |
PALIPERIDONE ER 6 MG TABLET paliperidone | $1.0460 per EA | +3.11% |
PALIPERIDONE ER 3 MG TABLET paliperidone | $0.9719 per EA | +6.57% |
PALIPERIDONE ER 1.5 MG TABLET paliperidone | $0.8204 per EA | +13.01% |
LACOSAMIDE 200 MG TABLET Lacosamide | $0.3159 per EA | — |
LACOSAMIDE 150 MG TABLET Lacosamide | $0.2856 per EA | — |
FEBUXOSTAT 80 MG TABLET febuxostat | $0.2610 per EA | -7.10% |
LACOSAMIDE 100 MG TABLET Lacosamide | $0.2451 per EA | — |
FEBUXOSTAT 40 MG TABLET febuxostat | $0.1911 per EA | -9.59% |
LACOSAMIDE 50 MG TABLET Lacosamide | $0.1487 per EA | — |
PREGABALIN 300 MG CAPSULE Pregabalin | $0.0772 per EA | — |
PREGABALIN 200 MG CAPSULE Pregabalin | $0.0661 per EA | — |
PREGABALIN 150 MG CAPSULE Pregabalin | $0.0641 per EA | — |
PREGABALIN 100 MG CAPSULE Pregabalin | $0.0609 per EA | — |
PREGABALIN 75 MG CAPSULE Pregabalin | $0.0604 per EA | — |
PREGABALIN 50 MG CAPSULE Pregabalin | $0.0535 per EA | — |
FDA Recalls (8)
Recalls matched by company name. Verify current status with FDA.
Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.
Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.
Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39961 3, NDC 50428-1252-4.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Free Non-Staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Family Dollar Services, Inc., 10301 Monroe Road, Matthews, NC 28105, NDC 55319-250-23, UPC 0 32251 03374 2.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syringe, Rx Only, Manufactured by: Tris Pharma, Inc. Monmouth Junction, NJ 08852, NDC 27808-082-01
Defective container: Oral solution leaking from container.